|
|
|
|
Vol. 9, Issue 3, 308-315, March 1999
METHODS
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
A highly efficient DNA sequencing strategy was developed on the basis of the bacteriophage Mu in vitro DNA transposition reaction. In the reaction, an artificial transposon with a chloramphenicol acetyltransferase (cat) gene as a selectable marker integrated into the target plasmid DNA containing a 10.3-kb mouse genomic insert to be sequenced. Bacterial clones carrying plasmids with the transposon insertions in different positions were produced by transforming transposition reaction products into Escherichia coli cells that were then selected on appropriate selection plates. Plasmids from individual clones were isolated and used as templates for DNA sequencing, each with two primers specific for the transposon sequence but reading the sequence into opposite directions, thus creating a minicontig. By combining the information from overlapping minicontigs, the sequence of the entire 10,288-bp region of mouse genome including six exons of mouse Kcc2 gene was obtained. The results indicated that the described methodology is extremely well suited for DNA sequencing projects in which considerable sequence information is on demand. In addition, massive DNA sequencing projects, including those of full genomes, are expected to benefit substantially from the Mu strategy.
[The sequence data reported in this paper have been submitted to the GenBank data library under accession no. AJ011033.]
| |
INTRODUCTION |
|---|
|
|
|---|
During the last decade, the sequenced DNA information has
accumulated with increasing pace. The yeast genome,
as well as a variety of microbial genomes, has already been sequenced
entirely, and projects destined to sequence several eukaryotic genomes
including those of man, mouse, fly, worm, and plant are being completed in the near future (Ash 1997
; Koonin 1997
; Beck and Sterk 1998
). Nevertheless, the need for DNA sequencing is not expected to be diminished. For example, comparative genome analyses, between species
or within species, that will yield a wealth of information concerning
principles of life, will necessarily involve massive DNA sequencing.
Efficient DNA sequencing strategy that will yield sequence information
reliably and rapidly is a necessity for a sequencing project. In
principle, the strategies used so far can be divided into three main
categories: (1) random, (2) directed, and (3) transposon-based
strategies. The most widely used strategy, especially for large-scale
DNA sequencing projects, is a random shotgun approach (for review, see
Hunkapiller et al. 1992
; Fraser and Fleischmann 1997
). Directed
strategies, typified by primer-walking and nested deletions, have been
used mainly to sequence DNA regions of moderate size (for review, see
Ansorge et al. 1997
). Transposon-based strategies combine features of
random and directed approaches and can be used efficiently in various
types of sequencing projects.
Several DNA sequencing strategies based on in vivo DNA transposition
reactions have been characterized (Adachi et al. 1987
; Phadnis et al.
1989
; Strathman et al. 1991
; Kasai et al. 1992
; Berg et al. 1993
).
However, in vivo approaches require special host strains and multiple
steps of manipulation that limit the usefulness of these strategies. In
addition, in some of the cases, a stringency of the target-site
selectivity was not optimal for sequencing purposes.
In vitro DNA transposition-based sequencing strategy has also been
described and shown to be highly useful, especially for sequencing
repetitive DNA (Devine and Boeke 1994
; Devine et al. 1997
). The system
utilized a customized artificial transposon in combination with
integrase activity present in purified yeast Ty1 retrotransposon
virus-like particles. However, no DNA sequencing strategy that would
utilize a single transposase protein in in vitro conditions has yet
been described. Such a system would be advantageous: Relative
simplicity of protein purification compared with that of protein
complexes, as well as at least potentially more preferable stability
characteristics of proteins, make a transposase-catalyzed reaction an
attractive choice for sequencing purposes.
Mu DNA transposition reaction is one of the best-characterized
transposition reactions (Mizuuchi 1992
a
,b
). In vivo, and in certain
reaction conditions with plasmid substrates in vitro, the reaction is
relatively complex and involves several protein and DNA cofactors (for
reviews, see Chaconas et al. 1996
; Lavoie and Chaconas 1996
) of which
the phage-encoded MuB protein affects target selection (Adzuma and
Mizuuchi 1988
, 1989
; Mizuuchi and Mizuuchi 1993
). However, with certain
DNA substrates and reaction conditions in vitro the requirements for
efficient transposition reaction are substantially relaxed (Craigie and
Mizuuchi 1986
, 1987
; Mizuuchi and Mizuuchi 1989
; Baker and Mizuuchi
1992
; Savilahti et al. 1995
). The minimal macromolecular components for
in vitro transposition into intermolecular targets are the MuA
transposase, the donor DNA, and the target DNA (Savilahti et al. 1995
).
The chemical steps of Mu transposition proceed within a protein-DNA complex called Mu transpososome that in its core contains the critical
components, a tetramer of MuA transposase and Mu DNA ends (Craigie and
Mizuuchi 1987
; Surette et al. 1987
; Lavoie et al. 1991
; Baker and
Mizuuchi 1992
; Baker et al. 1993
; Savilahti et al. 1995
). Initially,
the Mu transpososome core is assembled from four molecules of MuA and
two Mu DNA ends, and this underlining architecture is then maintained
throughout the two chemical steps of transposition. First, the
transposon DNA is cleaved at its 3' ends (called the donor
cleavage). Second, the target DNA is cut at staggered positions and the
target 5' ends are joined into the 3' ends of the transposon
DNA in a concerted reaction (called strand transfer). In vitro, the
first of the chemical steps can also be bypassed artificially by use of
a modified donor DNA substrate. It was shown that Mu donor DNA that was
cut precisely at Mu 3' ends by a restriction endonuclease was
efficiently utilized in transferring these precut 3' ends into the
target DNA (Craigie and Mizuuchi 1987
). In turn, this result brought
about an opportunity to use the Mu transposition reaction in a simple
manner for genetic manipulation.
In this paper we describe a highly efficient and easy methodology for
DNA sequencing that is based on the bacteriophage Mu in vitro
transposition reaction. As a test case, we used the system to determine
a 10,288-bp sequence from a mouse genomic locus containing a
Kcc2 gene. The respective protein, KCC2, is a
K+/Cl
cotransporter that is abundantly expressed
in brain and suggested to be involved in extruding chloride in mature
neurons (Payne et al. 1996
). We are currently producing mice with
targeted inactivation of Kcc2 and, for this purpose, the
sequence of the mouse genomic fragment was needed. Bacteriophage Mu in
vitro DNA transposition system proved to be very useful for DNA
sequencing purposes: (1) The reaction in vitro is simple; only one
protein component, the MuA transposase, is needed in addition to donor
DNA, target DNA, and buffer. (2) The transposition reaction is highly
efficient and reproducible in in vitro conditions. (3) The artificial
cat-Mu transposon contains an easily selectable marker,
chloramphenicol acetyltransferase gene (cat), that allows
convenient selection of integrants. (4) Mu in vitro transposition
produces relatively even distribution of integrations into the target DNA.
| |
RESULTS |
|---|
|
|
|---|
Experimental Outline
We developed a DNA sequencing strategy that is based on bacteriophage Mu in vitro DNA transposition reaction (Fig. 1). In the reaction, the artificial cat-Mu transposon integrated in vitro into the target plasmid DNA to be sequenced. The reaction products were then transformed into Escherichia coli cells and the bacteria were selected for antibiotic resistance to identify clones that carried target plasmids with cat-Mu transposon insertions. From the selected clones, a sequence on both sides of the inserted transposon was retrieved by use of two primers specific for the cat-Mu sequence. Each clone thus created a minicontig. The final sequence was obtained by assembling the overlapping minicontigs.
|
CAT-Mu Artificial Transposon
The CAT-Mu artificial transposon that was used as a donor DNA in
an in vitro transposition reaction contains the cat gene as
a selectable marker and flanking sequences with inverted 50-bp segments
of Mu right end sequence (Fig. 1A). This 1.2-kb transposon fragment was
released from its vector plasmid by BglII digestion that
leaves four nucleotide 5'-overhangs flanking the transposon sequence and thus generates the precut end configuration. The transposon end configuration has been shown to have an influence on
Mu transpososome core assembly and stability; precut molecules with
overhangs were among the most efficient in these respects (Savilahti et
al. 1995
; Savilahti and Mizuuchi 1996
). In addition, precut donor
molecules are readily available for the second chemical step of
transposition, the strand-transfer reaction (Craigie and Mizuuchi 1987
;
Savilahti et al. 1995
).
Transposition Reaction
We performed in vitro transposition reaction using a cat-Mu transposon fragment as a donor DNA and supercoiled plasmid pSR11 that contains the mouse genomic insert to be sequenced as a target DNA (Fig. 1B). In the reaction conditions used, most of the primary reaction products are open circular target molecules with an integrated transposon in different positions (data not shown). The molar ratio of donor to target was adjusted to avoid multiple transposon integrations into a single target molecule; such products would have been useless for sequencing purposes.
A portion of the reaction products was transformed into
electrocompetent E. coli DH5
cells and plated onto
selection plates containing chloramphenicol and ampicillin. The yield
of transformants was 540 colonies per 50 ng of target DNA with
electrocompetent DH5
cells that showed transformation efficiency
of ~107 cfu/µg pUC19 DNA. DNA from a control reaction
without MuA did not produce colonies.
Plasmids were prepared from 95 randomly chosen colonies by a quick boiling method. A restriction analysis was then performed with EcoRI-KpnI double digestion to identify the clones that had the transposon integrated into the cloned insert and not into the vector backbone of the plasmid (Fig. 2). Of the clones examined, 93 exhibited a clear restriction pattern consistent with a single transposon insertion in the plasmid. Plasmids from 79 clones contained the transposon in the cloned mouse DNA portion and 14 in the vector portion of the molecule. For the 71 selected clones, sequencing quality plasmid preparations were then generated and sequencing was performed with two cat-Mu specific primers that read the sequence from within the transposon but toward opposite directions (Tables 1 and 2). A total of 10,288 bp of sequence was retrieved (deposited in GenBank; accession no. AJ011033). On the average, ~500 bp could be read with one primer. Thus, an average length of a minicontig, connected from the data of two sequencing runs on the same template, was ~1000 bp. The location and orientation of each minicontig representing the 71 sites of cat-Mu insertions in plasmid pSR11 mouse DNA insert region are shown in Figures 2 and 3. The cat gene of the transposon was in the same relative orientation as the KCC2 gene in 36 clones; in 35 clones the orientation was opposite.
|
|
|
|
The exon-intron structure of the mouse genomic 10,288-bp Kcc2 fragment was compared with that of rat (Fig. 4). Six (putative) exons were identified that matched the sequence of rat Kcc2 cDNA (nucleotides 1-728, GenBank accession no. U55816). Nucleotide identity between the mouse exons and rat Kcc2 cDNA was 94%. Only a single amino acid difference between the mouse and rat KCC2 sequence was observed (mouse Arg-76 to rat Lys-76 in exon 3).
|
| |
DISCUSSION |
|---|
|
|
|---|
The development of an efficient DNA sequencing strategy that is based on the bacteriophage Mu in vitro DNA transposition reaction allowed us to rapidly sequence >10 kb of mouse genomic DNA (Tables 1 and 2). The system has many attractive features that allow the production of reliable sequence information effectively and accurately (Table 3).
|
The Mu in vitro reaction is relatively simple and easy to perform. The critical macromolecular components in the reaction are the MuA transposase, the donor DNA, and the target DNA. In addition, only a simple buffer with standard components including BSA, glycerol, Triton X-100, and MgCl2 is required. Because no purified protein complexes or protein-DNA complexes are needed, the preparation of the reaction components by standard molecular techniques is relatively straightforward. We note that the amount of artificial transposon fragment required for the reaction is on a nanogram scale. In practice, it follows that substrate donor DNA for a large number of reactions can be prepared economically and with minimum effort. We have also used PCR for donor DNA preparation and found the method satisfactory and quick (data not shown).
The Mu in vitro transposition reaction is highly efficient. With just
one 25-µl reaction, which contained only 18 ng of donor DNA and 500 ng of target DNA, and of which only one-tenth was electrotransformed
into E. coli cells, >500 bacterial clones containing plasmids with transposon inserts were produced. We used
electrocompetent E. coli cells that, in control
electrotransformation, yielded ~107 cfu/µg supercoiled
pUC19 DNA. The result indicated that if cells of extremely high
competence (e.g., competence of ~109 cfu/µg DNA) were
to be used, the maximum number of recoverable integrants from one
25-µl reaction would be 500,000. Such collection of
transposon-containing plasmids is expected to be appropriate even for
the most demanding sequencing projects and, in principle, all of the
clones needed for a project can easily be generated in a matter of one
day. The result also indicated that transformation frequencies that are
easily obtained with conventionally prepared competent cells (i.e.,
106-107 cfu/µg DNA) are efficient enough for
obtaining a sufficient number of clones for sequencing of lengthy
inserts. In fact, we have used the system in several sequencing
projects with competent cells prepared by the standard CaCl2
method (Sambrook et al. 1989
) and easily obtained several hundred
clones for sequencing purposes. Highly productive recovery of plasmids
with transposon insertions is the result of efficient in vitro reaction
as well as favorable primary reaction product profile. By adjusting
donor DNA concentration in the reaction, up to 10% of targets can be
converted to integrants, and essentially all primary reaction products
are derived from two-ended integrations of one donor molecule into the
target (data not shown). For comparison, the reported efficiency of Ty1
in vitro reaction was 1 insertion per 2.5 × 103 targets
(Devine and Boeke 1994
) and the system utilized electroporation as a
means to introduce transposon-containing plasmids into the host cells
(see Table 3).
The system used appears to recapitulate the genuine Mu transposition
reaction in that the hallmark target site duplication (Allet 1979
;
Kahmann and Kamp 1979
) is faithfully generated in the process. All of
the 71 sequenced clones contained a duplicated 5-bp target site
flanking the transposon. Furthermore, in several other projects we have
mapped by sequencing >200 integration sites and found the accurate
5-bp duplication in each of them. In favorable conditions, one
sequencing run can produce 500-800 nucleotides worth of sequence
information. Consequently, one minicontig can span a region of
1000-1600 nucleotides. Relatively few clones are therefore required to
sequence a typical cloned insert in a plasmid vector. We mapped the
transposon insertions with restriction enzyme cuts that distinguish
between insertions into the vector portion and into the few restriction
fragments of the insert portion of the plasmid. In some other cases,
however, and especially if most of the sequence has already been
retrieved, more accurate mapping or prescreen might be pertinent. An
efficient strategy would utilize an enzyme that cuts the transposon
sequence once or more but the rest of the plasmid only once.
One of the important aspects of artificial transposon is the selectable
marker that should provide a reliable identification for transposon
insertions. In the artificial cat-Mu transposon, we used a
cat gene that has been one of the most widely used selectable markers in bacterial genetics over the years (Sambrook et al. 1989
;
Miller 1992
). In this project, this gene also proved to be convenient
and easy to use for selection; we found no background colonies among
the clones studied (for comparison to the Ty1 system, see recovery of
clones in Table 3).
The cat-Mu insertions were recovered in all areas of the region to be
sequenced (Fig. 2 and Table 2) and their distribution was relatively
even (Fig. 3). The selection of target sequences by the MuA
transposase, therefore, appears to be random enough to be useful in DNA
sequencing. This situation contrasts with Mu reaction in vivo and with
plasmid substrates in vitro when MuB is included in the reaction.
Regional target preference was observed for which the MuB protein was
implicated (Mizuuchi and Mizuuchi 1993
). Recently, we have used the Mu
system also in other DNA sequencing projects and reproducibly found
similar, relatively even distribution of transposon insertions (data
not shown). In this study (see Table 2) the mean interval distance of
sequenced insertions needed to obtain the final sequence was ~150 bp
and thus well below the length of a typical sequencing run. Using an up
to date DNA sequencer, we experienced no difficulty in producing reliable final sequence with these 71 insertions even though the maximum insertion distance was as long as 570 bp. However, in some
cases, it may be desirable to lower the mean interval distance of
insertions; this can be done by simply sequencing more insertions. Our
data indicate that for obtaining reliable final sequence for a 2-kb
insert (with typical sequencing parameters used in this study, see
Table 1) ~10 clones need to be sequenced (see the 2322-bp and
2239-bp fragments in Fig. 2). However, when longer inserts (without
prescreening) are to be sequenced, on the basis of statistics of random
insertions, relatively more clones are progressively required (see also
the 5727-bp fragment in Fig. 2).
The described in vitro system is easily amenable to modifications to meet the needs of various sequencing projects. For example, different selectable marker genes may be desirable instead of the cat gene; any selectable or screenable marker is expected to be usable in minitransposons between the Mu ends. For screening purposes, a transposon containing a rare restriction site such as NotI might be desirable. PCR-based screening strategies will probably be very useful for mapping of individual transposon insertion sites.
The Mu in vitro transposition reaction-based DNA sequencing strategy is simple and, therefore, amenable to automatization. Consequently, high-throughput sequencing projects are expected to benefit substantially from the described Mu strategy. The system is currently in routine use in the sequencing facility of the Institute of Biotechnology and it is regarded as the method of choice for miscellaneous DNA sequencing projects.
| |
METHODS |
|---|
|
|
|---|
Proteins, Plasmids, and Reagents
MuA was overexpressed and purified in collaboration with Finnzymes
(Espoo, Finland) essentially as described (Baker et al. 1993
) except
that the chromatographic steps were performed on heparin-agarose
(Kemotex, Tallinn, Estonia) and Mono S (Pharmacia). The target for
transposition-aided sequencing was plasmid pSR11 containing a 10.3-kb
mouse genomic EcoRI-SalI insert. The insert was
screened from a 129/Sv mouse library (Stratagene) with a rat Kcc2 cDNA (Payne et al. 1996
) fragment as a probe and
subcloned into pBluescript II SK+ (Stratagene) vector backbone between
EcoRI and SalI sites. The plasmid was purified by use
of a Qiagen plasmid purification kit. Restriction endonucleases were
from New England Biolabs, T4 DNA ligase from Life Technologies, BSA
from Sigma, Triton X-100 from Boehringer Mannheim, and agarose from Promega.
cat-Mu Artificial Transposon
Construction of the cat-Mu artificial transposon-containing
plasmid will be described in detail elsewhere. The cat-Mu transposon (Fig. 1A) contains the CAT gene from plasmid pBC SK+
(Stratagene) that is flanked by a pair of 50-bp Mu right-end segments
(Savilahti et al. 1995
) in inverted orientation relative to each other.
From the vector plasmid, the transposon fragment was released by
BglII digestion that leaves four nucleotide 5'-overhangs
flanking the exposed transposon ends. The cat-Mu transposon is
therefore in precut configuration that ensures efficient transpososome
assembly and stability (Savilahti et al. 1995
; Savilahti and Mizuuchi
1996
). The cat-Mu fragment was purified chromatographically with a
TSK-gel DNA-NPR (Tosohaas, Stuttgart, Germany) anion exchange column.
In Vitro Transposition Reactions
In vitro transposition reaction (Fig. 1B) was performed with the cat-Mu artificial transposon as a donor DNA and plasmid pSR11 as a target DNA. Transposition reactions (25 µl) contained 0.02 pmole (18 ng) donor, 0.06 pmole (500 ng) target, 2.7 pmoles (0.2 µg) MuA, 25 mM Tris-HCl at pH 8.0, 100 µg/ml BSA, 15% (wt/vol) glycerol, 0.05% (wt/vol) Triton X-100, 126 mM NaCl, and 10 mM MgCl2. Reactions were carried out at 30°C for 1 hr and stopped by freezing in liquid nitrogen.
Recovery of Plasmids Carrying Inserted CAT-Mu Transposon and Insertion Screen
In vitro transposition reaction was sequentially phenol and
chloroform extracted, ethanol precipitated, washed with 75% ethanol, dried, and resuspended in 5 µl of TEN buffer (10 mM
Tris-HCl at pH 7.5, 0.5 mM EDTA, 50 mM NaCl). From
the reaction, 0.5 µl was then electrotransformed into 25 µl of
competent E. coli DH5
(Life Technologies) cells prepared
as described (Ausubel et al. 1989
). Electrotransformation was done with
1-mm cuvettes in a Bio-Rad Genepulser II with the following settings:
capacitance, 25 µF; voltage 1.8 kV; and resistance, 200 ohms. One
milliliter of Luria Broth (LB) was then added, and the bacteria were
grown for 1 hr at 37°C, collected by centrifugation, and plated on
LB plates containing chloramphenicol (5 µg/ml) and ampicillin (100 µg/ml). Plasmid preparations were made from colonies obtained by a
quick boiling method (Holmes and Quigley 1981
). To distinguish between transposon insertions into the vector portion of the plasmid and those
into the cloned mouse DNA insert, a restriction analysis was performed
by KpnI and EcoRI double digestion (Fig. 2) in CA buffer (20 mM Tris-HCl at pH 7.5, 7 mM
MgCl2, 100 mM KCl, 2 mM
-mercaptoethanol).
DNA Techniques, Sequencing, and Data Analysis
Standard DNA techniques were performed as described (Sambrook et
al. 1989
). Plasmids for sequencing were prepared by use of a QIAprep
Spin Miniprep kit (Qiagen). The transposon specific primers were as
follows: Muc1 (5'-GCTCTCCCCGTGGAGGTAAT-3') and Muc2
(5'-TTCCGTCACAGGTATTTATTCGGT-3'). The vector specific primers for sequencing the ends of cloned mouse insert were as follows: RP
(5'- TTTCACACAGGAAACAGCTATGAC-3') and UP
(5'-CGACGTTGTAAAACGACGGCCAGT-3'). Sequencing reactions were
performed with a BigDye terminator cycle sequencing kit (Perkin Elmer)
and analyzed by an ABI 377 XL automated DNA sequencer (Perkin Elmer).
The sequence assembly and data analysis were done by the xgap program
in the Staden Package (Bonfield et al. 1995
) on a SUN workstation. The
sequence has been deposited in the European Molecular Biology
Laboratory GenBank under accession number AJ011033.
| |
ACKNOWLEDGMENTS |
|---|
Sari Nieminen, Pirjo Rahkola, and Noora Salovuori are acknowledged for excellent technical assistance. Dr. John Payne kindly provided the rat Kcc2 cDNA. We thank Erkki Koivunen, Arja Lamberg, and Pekka Lappalainen for critical comments on the manuscript and Hannu Rita for valuable suggestions concerning statistical analysis of the data. Financial support was obtained from Biocentrum Helsinki (to M.A., L.P., and H.S.), Academy of Finland (to M.A. and H.S.), Technology Development Centre (to H.S.), and Oskar Öflund Foundation (to S.S.).
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
NOTE ADDED IN PROOF |
|---|
More information about the function of the
K+/Cl
cotransporter KCC2 is now available
(Rivera et al. 1998, Nature 397: 251-255).
| |
FOOTNOTES |
|---|
1 Corresponding author.
E-MAIL harri.savilahti{at}helsinki.fi; FAX 358-9-708 59366.
| |
REFERENCES |
|---|
|
|
|---|
.
Proc. Natl. Acad. Sci.
86:
5908-5912Received October 5, 1998; accepted in revised form January 5, 1999.
This article has been cited by other articles:
![]() |
M. Pajunen, H. Turakainen, E. Poussu, J. Peranen, M. Vihinen, and H. Savilahti High-precision mapping of protein protein interfaces: an integrated genetic strategy combining en masse mutagenesis and DNA-level parallel analysis on a yeast two-hybrid platform Nucleic Acids Res., August 15, 2007; (2007) gkm563v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Orsini, M. Pajunen, I. Hanski, and H. Savilahti SNP discovery by mismatch-targeting of Mu transposition Nucleic Acids Res., March 19, 2007; 35(6): e44 - e44. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krupovic, H. Vilen, J. K. H. Bamford, H. M. Kivela, J.-M. Aalto, H. Savilahti, and D. H. Bamford Genome Characterization of Lipid-Containing Marine Bacteriophage PM2 by Transposon Insertion Mutagenesis. J. Virol., September 1, 2006; 80(18): 9270 - 9278. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Poussu, J. Jantti, and H. Savilahti A gene truncation strategy generating N- and C-terminal deletion variants of proteins for functional studies: mapping of the Sec1p binding domain in yeast Mso1p by a Mu in vitro transposition-based approach Nucleic Acids Res., July 8, 2005; 33(12): e104 - e104. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Pajunen, A. T. Pulliainen, J. Finne, and H. Savilahti Generation of transposon insertion mutant libraries for Gram-positive bacteria by electroporation of phage Mu DNA transposition complexes Microbiology, April 1, 2005; 151(4): 1209 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Song, S. Hwang, W. H. Wong, T.-T. Wu, S. Lee, H.-I Liao, and R. Sun Identification of viral genes essential for replication of murine {gamma}-herpesvirus 68 using signature-tagged mutagenesis PNAS, March 8, 2005; 102(10): 3805 - 3810. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Vilen, J.-M. Aalto, A. Kassinen, L. Paulin, and H. Savilahti A Direct Transposon Insertion Tool for Modification and Functional Analysis of Viral Genomes J. Virol., December 6, 2002; 77(1): 123 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shevchenko, G. G. Bouffard, Y. S. N. Butterfield, R. W. Blakesley, J. L. Hartley, A. C. Young, M. A. Marra, S. J. M. Jones, J. W. Touchman, and E. D. Green Systematic sequencing of cDNA clones using the transposon Tn5 Nucleic Acids Res., June 1, 2002; 30(11): 2469 - 2477. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lamberg, S. Nieminen, M. Qiao, and H. Savilahti Efficient Insertion Mutagenesis Strategy for Bacterial Genomes Involving Electroporation of In Vitro-Assembled DNA Transposition Complexes of Bacteriophage Mu Appl. Envir. Microbiol., February 1, 2002; 68(2): 705 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Griffin 4th, L. Parsons, A. E. Leschziner, J. DeVost, K. M. Derbyshire, and N. D. Grindley In vitro transposition of Tn552: a tool for DNA sequencing and mutagenesis Nucleic Acids Res., October 1, 1999; 27(19): 3859 - 3865. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Haapa-Paananen, H. Rita, and H. Savilahti DNA Transposition of Bacteriophage Mu. A QUANTITATIVE ANALYSIS OF TARGET SITE SELECTION IN VITRO J. Biol. Chem., January 18, 2002; 277(4): 2843 - 2851. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kekarainen, H. Savilahti, and J. P.T. Valkonen Functional Genomics on Potato Virus A: Virus Genome-Wide Map of Sites Essential for Virus Propagation Genome Res., April 1, 2002; 12(4): 584 - 594. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||